{
  "id": "adv_mhgap#screening_cues_9fb4bf65",
  "content": "90\n3. Recommendations\ny There is a moderate-to-large increase of adverse y Polytherapy should be avoided as a treatment\neffects (discontinuation due to adverse effects) option when commencing maintenance therapy.\ndepending on the medicine used.\nResearch gaps\ny The certainty of evidence was moderate for the\noutcome recurrence. The certainty of evidence was y There is limited evidence on how long antipsychotic\nvery low to low for the outcome adverse effects. medicine or mood stabilizers should be continued\nafter remission for first episode bipolar disorder.\nRemarks y Most of the evidence is from HICs. Further research is\ny This recommendation refers to people living needed in LMICs.\nwith bipolar disorder in the maintenance phase,\nImplementation considerations\ncharacterized by the absence of acute symptoms.\ny The use of lithium should be considered as first-line y People living with bipolar disorder should be\nof treatment for bipolar disorder only if clinical and involved in medicine choice in a supported\nlaboratory monitoring are available and should decision-making process.\nonly be prescribed under mental health specialist y Treatment with antipsychotic medicines or mood\nsupervision. If laboratory examinations are not stabilizers should be combined with psychosocial",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General â€” Screening Cues 90\n3. Recommendations\ny There is a moderate-to-large increase of adverse y Polytherapy should be avoided as a treatment\neffects (discontinuation due to adverse effects) option when commencing maintenance therapy.\ndepending on the medicine used.\nResearch gaps\ny The certainty of evidence was moderate for the\noutcome recurrence. The certainty of evidence was y There is limited evidence on how long antipsychotic\nvery low to low for the outcome adverse effects. medicine or mood stabilizers should be continued\nafter remission for first episode bipolar disorder.\nRemarks y Most of the evidence is from HICs. Further research is\ny This recommendation refers to people living needed in LMICs.\nwith bipolar disorder in the maintenance phase,\nImplementation considerations\ncharacterized by the absence of acute symptoms.\ny The use of lithium should be considered as first-line y People living with bipolar disorder should be\nof treatment for bipolar disorder only if clinical and involved in medicine choice in a supported\nlaboratory monitoring are available and should decision-making process.\nonly be prescribed under mental health specialist y Treatment with antipsychotic medicines or mood\nsupervision. If laboratory examinations are not stabilizers should be combined with psychosocial 90\n3. recommendations\ny there is a moderate-to-large increase of adverse y polytherapy should be avoided as a treatment\neffects (discontinuation due to adverse effects) option when commencing maintenance therapy."
}